CD137-CD137 Ligand Interactions in Inflammation

Overview

Journal Immune Netw

Specialty Allergy & Immunology

Date 2010 Jan 29

PMID 20107537

Citations 23

Authors

Byungsuk Kwon

Affiliations

Soon will be listed here.

Abstract

The main stream of CD137 studies has been directed to the function of CD137 in CD8(+) T-cell immunity, including its anti-tumor activity, and paradoxically the immunosuppressive activity of CD137, which proves to be of a great therapeutic potential for animal models of a variety of autoimmune and inflammatory diseases. Recent studies, however, add complexes to the biology of CD137. Accumulating is evidence supporting that there exists a bidirectional signal transduction pathway for the CD137 receptor and its ligand (CD137L). CD137/CD137L interactions are involved in the network of hematopoietic and nonhematopoietic cells in addition to the well characterized antigen-presenting cell-T cell interactions. Signaling through CD137L plays a critical role in the differentiation of myeloid cells and their cellular activities, suggesting that CD137L signals trigger and sustain inflammation. The overall consequence might be that the amplified inflammation by CD137L enhances the T-cell activity together with CD137 signals by upregulating costimulatory molecules, MHC molecules, cell adhesion molecules, cytokines, and chemokines. Solving this outstanding issue is urgent and will have an important clinical implication.

Citing Articles

Is Associated with Favorable Tumor Immune Microenvironment in Patients with Renal Cell Carcinoma Who Are Treated with the Combination Therapy of Nivolumab and Ipilimumab.

Isoda B, Kandori S, Sazuka T, Kojima T, Nitta S, Shiga M Int J Mol Sci. 2024; 25(13).

PMID: 39000552 PMC: 11242552. DOI: 10.3390/ijms25137444.

Cyclosporine A-resistant CAR-T cells mediate antitumour immunity in the presence of allogeneic cells.

Zhang Y, Fang H, Wang G, Yuan G, Dong R, Luo J Nat Commun. 2023; 14(1):8491.

PMID: 38123592 PMC: 10733396. DOI: 10.1038/s41467-023-44176-0.

Immune checkpoint molecules in prevention and development of asthma.

Kanannejad Z, Soleimanian S, Ghahramani Z, Sepahi N, Mohkam M, Alyasin S Front Immunol. 2023; 14:1070779.

PMID: 36865540 PMC: 9972681. DOI: 10.3389/fimmu.2023.1070779.

PRRSV-1 induced lung lesion is associated with an imbalance between costimulatory and coinhibitory immune checkpoints.

Ruedas-Torres I, Sanchez-Carvajal J, Carrasco L, Pallares F, Larenas-Munoz F, Rodriguez-Gomez I Front Microbiol. 2023; 13:1007523.

PMID: 36713151 PMC: 9878400. DOI: 10.3389/fmicb.2022.1007523.

4-1BB: A promising target for cancer immunotherapy.

Kim A, Nemeth M, Lim S Front Oncol. 2022; 12:968360.

PMID: 36185242 PMC: 9515902. DOI: 10.3389/fonc.2022.968360.

References

Takahashi C, Mittler R, Vella A . Cutting edge: 4-1BB is a bona fide CD8 T cell survival signal. J Immunol. 1999; 162(9):5037-40. View

Fukushima A, Yamaguchi T, Ishida W, Fukata K, Mittler R, Yagita H . Engagement of 4-1BB inhibits the development of experimental allergic conjunctivitis in mice. J Immunol. 2005; 175(8):4897-903. DOI: 10.4049/jimmunol.175.8.4897. View

Jiang D, Chen Y, Schwarz H . CD137 induces proliferation of murine hematopoietic progenitor cells and differentiation to macrophages. J Immunol. 2008; 181(6):3923-32. DOI: 10.4049/jimmunol.181.6.3923. View

Kang Y, Kim S, Shimada S, Otsuka M, Seit-Nebi A, Kwon B . Cell surface 4-1BBL mediates sequential signaling pathways 'downstream' of TLR and is required for sustained TNF production in macrophages. Nat Immunol. 2007; 8(6):601-9. DOI: 10.1038/ni1471. View

Kim J, Kim H, Park K, Kim J, Choi H, Yagita H . Costimulatory molecule-targeted immunotherapy of cutaneous graft-versus-host disease. Blood. 2007; 110(2):776-82. DOI: 10.1182/blood-2006-08-043612. View

Wilcox R, Tamada K, Strome S, Chen L . Signaling through NK cell-associated CD137 promotes both helper function for CD8+ cytolytic T cells and responsiveness to IL-2 but not cytolytic activity. J Immunol. 2002; 169(8):4230-6. DOI: 10.4049/jimmunol.169.8.4230. View

Kim D, Chang W, Lee Y, Lee K, Kim Y, Kwon B . 4-1BB engagement costimulates NKT cell activation and exacerbates NKT cell ligand-induced airway hyperresponsiveness and inflammation. J Immunol. 2008; 180(4):2062-8. DOI: 10.4049/jimmunol.180.4.2062. View

Lippert U, Zachmann K, Ferrari D, Schwarz H, Brunner E, Mahbub-Ul Latif A . CD137 ligand reverse signaling has multiple functions in human dendritic cells during an adaptive immune response. Eur J Immunol. 2008; 38(4):1024-32. DOI: 10.1002/eji.200737800. View

Kwon B, Moon C, Kang S, Seo S, Kwon B . 4-1BB: still in the midst of darkness. Mol Cells. 2000; 10(2):119-26. DOI: 10.1007/s10059-000-0119-0. View

10.

McHugh R, Whitters M, Piccirillo C, Young D, Shevach E, Collins M . CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity. 2002; 16(2):311-23. DOI: 10.1016/s1074-7613(02)00280-7. View

11.

Olofsson P, Soderstrom L, Wagsater D, Sheikine Y, Ocaya P, Lang F . CD137 is expressed in human atherosclerosis and promotes development of plaque inflammation in hypercholesterolemic mice. Circulation. 2008; 117(10):1292-301. DOI: 10.1161/CIRCULATIONAHA.107.699173. View

12.

Seo S, Choi J, Kim Y, Kang W, Park H, Suh J . 4-1BB-mediated immunotherapy of rheumatoid arthritis. Nat Med. 2004; 10(10):1088-94. DOI: 10.1038/nm1107. View

13.

Lee S, Ju S, Pack H, Heo S, Suh J, Park S . 4-1BB (CD137) is required for rapid clearance of Listeria monocytogenes infection. Infect Immun. 2005; 73(8):5144-51. PMC: 1201223. DOI: 10.1128/IAI.73.8.5144-5151.2005. View

14.

Drenkard D, Becke F, Langstein J, Spruss T, Kunz-Schughart L, Tan T . CD137 is expressed on blood vessel walls at sites of inflammation and enhances monocyte migratory activity. FASEB J. 2006; 21(2):456-63. DOI: 10.1096/fj.05-4739com. View

15.

Cheung C, Deisher T, Luo H, Yanagawa B, Bonigut S, Samra A . Neutralizing anti-4-1BBL treatment improves cardiac function in viral myocarditis. Lab Invest. 2007; 87(7):651-61. DOI: 10.1038/labinvest.3700563. View

16.

Vinay D, Choi B, Bae J, Kim W, Gebhardt B, Kwon B . CD137-deficient mice have reduced NK/NKT cell numbers and function, are resistant to lipopolysaccharide-induced shock syndromes, and have lower IL-4 responses. J Immunol. 2004; 173(6):4218-29. DOI: 10.4049/jimmunol.173.6.4218. View

17.

Nishimoto H, Lee S, Hong H, Potter K, Maeda-Yamamoto M, Kinoshita T . Costimulation of mast cells by 4-1BB, a member of the tumor necrosis factor receptor superfamily, with the high-affinity IgE receptor. Blood. 2005; 106(13):4241-8. PMC: 1416206. DOI: 10.1182/blood-2005-04-1358. View

18.

Lee S, Park Y, So T, Kwon B, Cheroutre H, Mittler R . Identification of regulatory functions for 4-1BB and 4-1BBL in myelopoiesis and the development of dendritic cells. Nat Immunol. 2008; 9(8):917-26. PMC: 2561255. DOI: 10.1038/ni.1632. View

19.

Croft M . The role of TNF superfamily members in T-cell function and diseases. Nat Rev Immunol. 2009; 9(4):271-85. PMC: 2737409. DOI: 10.1038/nri2526. View

20.

Saito K, Ohara N, Hotokezaka H, Fukumoto S, Yuasa K, Naito M . Infection-induced up-regulation of the costimulatory molecule 4-1BB in osteoblastic cells and its inhibitory effect on M-CSF/RANKL-induced in vitro osteoclastogenesis. J Biol Chem. 2004; 279(14):13555-63. DOI: 10.1074/jbc.M303791200. View